Immunohistochemistry can aid in differentiating KFD from lymphomas [1] but should never replace the hematoxylin and eosin evaluation of an adequate sample, as MPO positivity could be misinterpreted as myeloid sarcoma [69]. This evidence concerns the gene MPO and myeloid sarcoma.